Literature DB >> 9041436

The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

C Lara1, M Sällberg, B Johansson, I L de Rivera, A Sönnerborg.   

Abstract

The distribution of subtypes A through F of human immunodeficiency virus type 1 (HIV-1) in Honduras was analyzed in 120 HIV-1 positive serum samples by V3 peptide serotyping and HIV-1 cDNA sequencing. In the Honduran HIV-1 epidemic, subtype B was detected in 98 of 99 subtyped samples.

Entities:  

Keywords:  Americas; Biology; Central America; Developing Countries; Diseases; Genetics; Hiv; Hiv Infections; Honduras; Latin America; North America; Research Report; Viral Diseases

Mesh：

Substances：

Year:  1997        PMID： 9041436      PMCID： PMC229674          DOI： 10.1128/jcm.35.3.783-784.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Longstanding presence in Belgians of multiple non-B HIV-1 subtypes.

Authors:  K Fransen; A Buvé; J N Nkengasong; M Laga; G van der Groen
Journal:  Lancet       Date:  1996-05-18       Impact factor: 79.321

2.  Diverse HIV-1 genetic subtypes in UK.

Authors:  J P Clewley; C Arnold; K L Barlow; P R Grant; J V Parry
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

3.  Multiple introductions of HIV-1 subtype E into the western hemisphere.

Authors:  A W Artenstein; J Coppola; A E Brown; J K Carr; E Sanders-Buell; E Galbarini; J R Mascola; T C VanCott; P Schonbrood; F E McCutchan
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

4.  Detection of diverse HIV-1 genetic subtypes in the USA.

Authors:  S K Brodine; J R Mascola; P J Weiss; S I Ito; K R Porter; A W Artenstein; F C Garland; F E McCutchan; D S Burke
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

5.  Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.

Authors:  C P Pau; S Lee-Thomas; W Auwanit; J R George; C Y Ou; B S Parekh; T C Granade; D L Holloman; S Phillips; G Schochetman
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

6.  Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay.

Authors:  A Cabello; M Cabral; M E Vera; R Kiefer; R M Azorero; J Eberle; L Gürtler; A Von Brunn
Journal:  AIDS Res Hum Retroviruses       Date:  1995-09       Impact factor: 2.205

7.  Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.

Authors:  J Louwagie; E L Delwart; J I Mullins; F E McCutchan; G Eddy; D S Burke
Journal:  AIDS Res Hum Retroviruses       Date:  1994-05       Impact factor: 2.205

8.  Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization.

Authors:  C P Pau; M Kai; D L Holloman-Candal; C C Luo; M L Kalish; G Schochetman; B Byers; J R George
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

9.  Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

Authors:  R Q Warren; M T Wong; G P Melcher; S P Blatt; P Cahn; H Perez; I Zapiola; M B Bouzas; G Muchinik; S A Anderson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.

Authors:  K Sherefa; A Sönnerborg; J Steinbergs; M Sällberg
Journal:  Biochem Biophys Res Commun       Date:  1994-12-30       Impact factor: 3.575
  10 in total
  2 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades.

Authors:  Yaxelis Mendoza; Alexander A Martínez; Juan Castillo Mewa; Claudia González; Claudia García-Morales; Santiago Avila-Ríos; Gustavo Reyes-Terán; Blas Armién; Juan M Pascale; Gonzalo Bello
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.